ArticlePloS one2023

Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton's tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics.

Ryohei Kozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.